Research Facility

Lexington, Kentucky 40536

3 studies enrolling now · 4 studies all time

What they study most

Anemia, Carcinoid, Carcinoid Tumor, Chronic Kidney Disease, Chronic Renal Failure, GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Hepatocellular Carcinoma (HCC), Neuroendocrine Tumors, Pancreatic NET, Solid Tumor

Studies at this site

• Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. — Recruiting now
• Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC — Recruiting now
• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy — Recruiting now
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis — Completed